Lifecore Biomedical
LFCR
107 hedge funds and large institutions have $301M invested in Lifecore Biomedical in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 41 reducing their positions, and 8 closing their positions.
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
6% more funds holding
Funds holding: 101 → 107 (+6)
0% less capital invested
Capital invested by funds: $302M → $301M (-$1.34M)
15% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wynnefield Capital
New York
|
+$11.4M |
| 2 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$10.8M |
| 3 |
RA
Royce & Associates
New York
|
+$2.02M |
| 4 |
IA
Icon Advisers
Greenwood Village,
Colorado
|
+$1.95M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
-$11.4M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$7.43M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.95M |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$1.8M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.63M |
LFCR Hedge Fund Activity: Q3 2014 in Review
107 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q3 2014, worth a combined $301M — down 0.44% from $302M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new LFCR positions and 8 closed out — a net gain of 7 holders — while 35 added to existing stakes and 41 trimmed.
The largest buyer was Wynnefield Capital, adding an estimated $11.4M. The largest seller was Opus Capital Group, cutting an estimated $11.4M.
- 107 institutional investors held Lifecore Biomedical (LFCR) as of Q3 2014, up from 101 in Q2 2014.
- Funds reported $301M of Lifecore Biomedical stock for Q3 2014, down 0.44% quarter-over-quarter.
- 15 funds opened new Lifecore Biomedical positions in Q3 2014 and 8 closed out, a net change of +7 holders.
- The largest Lifecore Biomedical buyer in Q3 2014 was Wynnefield Capital, an estimated $11.4M added.
- The largest Lifecore Biomedical seller in Q3 2014 was Opus Capital Group, an estimated $11.4M sold.
Based on aggregated 13F filings for Q3 2014.